Catalyst
Slingshot members are tracking this event:
Top-Line Phase 3 Data of cabozantinib (CELESTIAL trial) for Patients with Advanced Hepatocellular Cancer (HCC) Due 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EXEL |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 16, 2017
Occurred Source:
http://ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2308693
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Data, Cabozantinib, Celestial Trial, Advanced Hepatocellular Cancer, Hcc, Top-line Data, Phase 3
